Jeff Yass’s P3 Health Partners PIII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,371
Closed -$41.2K 14263
2026
Q1
$41.2K Buy
+13,371
New +$35.2K ﹤0.01% 12682
2024
Q3
Sell
-5,179
Closed -$117K 12775
2024
Q2
$117K Buy
+5,179
New +$155K ﹤0.01% 10905
2024
Q1
Sell
-965
Closed -$68K 13077
2023
Q4
$68K Buy
965
+84
+10% +$5.79K ﹤0.01% 11564
2023
Q3
$64.7K Buy
881
+621
+239% +$64.5K ﹤0.01% 11179
2023
Q2
$38.9K Sell
260
-58
-18% -$8.02K ﹤0.01% 11432
2023
Q1
$16.9K Buy
+318
New +$19.1K ﹤0.01% 12088
2022
Q4
Sell
-234
Closed -$54K 13375
2022
Q3
$54K Buy
+234
New +$58.5K ﹤0.01% 12152
2021
Q4
Sell
-3,000
Closed -$1.48M 13717
2021
Q3
$1.48M Hold
3,000
﹤0.01% 6524
2021
Q2
$1.48M Buy
+3,000
New +$1.47M ﹤0.01% 6671

Other funds holding PIII

Jeff Yass's PIII Position: Q2 2026 in Review

Jeff Yass sold out of P3 Health Partners (PIII) in Q2 2026, closing a stake of 13,371 shares — an estimated $41.2K sold.

Jeff Yass first reported a position in PIII in Q2 2021 and held it in 9 quarters. The position peaked at $1.48M in Q2 2021. 21 funds tracked by Wall St. Rank hold PIII as of Q2 2026.

  • Jeff Yass reported no remaining P3 Health Partners position as of Q2 2026 after selling out during the quarter.
  • Jeff Yass sold 13,371 P3 Health Partners shares in Q2 2026, an estimated $41.2K.
  • Jeff Yass first reported a position in P3 Health Partners in Q2 2021 and held it in 9 quarters.
  • Jeff Yass's P3 Health Partners position peaked at $1.48M in Q2 2021.
  • 21 funds tracked by Wall St. Rank held P3 Health Partners as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.